STAT1 and Miyoshi myopathy: Although panobinostat alone did not activate the STAT1-IRF1 pathway in MM cells (Figure 2B), panobinostat further enhanced the total and phosphorylated levels of STAT1 protein but reduced IRF1 protein levels in MM cells in the presence of IFN-γ (Figure 3C).